China Health Group Limited (HKG:0673)
0.8000
-0.0100 (-1.23%)
Jan 21, 2026, 3:42 PM HKT
China Health Group Revenue
China Health Group had revenue of 19.61M HKD in the half year ending September 30, 2025, a decrease of -30.63%. This brings the company's revenue in the last twelve months to 39.87M, down -20.80% year-over-year. In the fiscal year ending March 31, 2025, China Health Group had annual revenue of 38.94M, down -35.02%.
Revenue (ttm)
39.87M
Revenue Growth
-20.80%
P/S Ratio
27.20
Revenue / Employee
313.96K
Employees
148
Market Cap
1.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 38.94M | -20.99M | -35.02% |
| Mar 31, 2024 | 59.93M | -16.48M | -21.57% |
| Mar 31, 2023 | 76.41M | -30.61M | -28.60% |
| Mar 31, 2022 | 107.03M | 19.14M | 21.77% |
| Mar 31, 2021 | 87.89M | 42.73M | 94.62% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 626.85B |
| Charmacy Pharmaceutical | 4.65B |
| Sipai Health Technology | 3.75B |
| IVD Medical Holding | 3.37B |
| Sinco Pharmaceuticals Holdings | 2.73B |
| ClouDr Group | 2.47B |
| 160 Health International | 698.59M |
| Ziyuanyuan Holdings Group | 575.61M |